Lupus-like skin Eruptions as Indicator of Disease Progression and Poor Outcome in Patients with Haematological Malignancies.

Acta Derm Venereol

Department of Dermatology, Venerology and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University Witten/Herdecke, DE-46045 Oberhausen, Germany. E-mail:

Published: July 2021

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413775PMC
http://dx.doi.org/10.2340/00015555-3865DOI Listing

Publication Analysis

Top Keywords

lupus-like skin
4
skin eruptions
4
eruptions indicator
4
indicator disease
4
disease progression
4
progression poor
4
poor outcome
4
outcome patients
4
patients haematological
4
haematological malignancies
4

Similar Publications

Objective: Systemic lupus erythematosus (SLE) is a systemic autoimmune syndrome characterized by autoreactive responses to nucleic acids, dysregulation of the type I interferon (IFN-I) pathway, and accelerated atherosclerosis. The stimulator of IFN genes (STING), a cytosolic DNA sensor, has pathogenic implications in various inflammatory diseases. However, its specific role in SLE pathogenesis, particularly in tissue damage, remains unclear.

View Article and Find Full Text PDF
Article Synopsis
  • Hydralazine has been used for many years to treat high blood pressure, but it can cause serious side effects, including autoimmune diseases like ANCA-vasculitis and a lupus-like syndrome.
  • The text discusses four cases of vasculitis linked to hydralazine, showing varying symptoms like lung hemorrhage, coughing up blood, and skin rashes.
  • Diagnosing these conditions can be challenging, often requiring kidney biopsy, and the treatment involves stopping hydralazine and using immunosuppressants; caution is advised in using hydralazine over other blood pressure medications.
View Article and Find Full Text PDF

A rare cause of immune dysregulation, prolidase deficiency: a case report and review of the literature.

Immunol Res

December 2024

Division of Pediatric Genetics, Department of Child Health and Diseases, Faculty of Medicine Hospital, Dokuz Eylul University, Izmir, Turkey.

We report a pediatric patient with prolidase deficiency, caused by a mutation in the PEPD gene, which encodes the enzyme prolidase D, with a lupus-like clinic and marked dysmorphic features along with pulmonary, neurological, skeletal, and immune system involvement. In addition to being the first known case in the literature where Friedrich's ataxia and prolidase deficiency were observed together, we aimed to highlight that this diagnosis should be considered in patients with autoimmunity and additional systemic findings such as treatment-resistant skin lesions, intellectual disability, and pulmonary manifestations. Furthermore, we sought to compare this case with others documented in the literature.

View Article and Find Full Text PDF

Deletion of the Mitochondrial Membrane Protein Fam210b Is Associated with the Development of Systemic Lupus Erythematosus.

Int J Mol Sci

July 2024

Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, No. 10 Xitoutiao, You An Men, Beijing 100069, China.

Mitochondrial dysfunction has been increasingly recognized as a trigger for systemic lupus erythematosus (SLE). Recent bioinformatics studies have suggested Fam210b as a significant candidate for the classification and therapeutic targeting of SLE. To experimentally prove the role of Fam210b in SLE, we constructed knockout () mice using the CRISPR-Cas9 method.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!